Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis

被引：0
|
作者：
Giuseppe Rosiello
Carlotta Palumbo
Sophie Knipper
Angela Pecoraro
Stefano Luzzago
Pierre-Antoine St-Hilaire
Zhe Tian
Umberto Capitanio
Francesco Montorsi
Shahrokh F. Shariat
Fred Saad
Alberto Briganti
Pierre I. Karakiewicz
机构：
[1] University of Montreal Health Center,Cancer Prognostics and Health Outcomes Unit, Division of Urology
[2] IRCCS San Raffaele Scientific Institute,Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute
[3] University of Brescia,Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health
[4] University Hospital Hamburg-Eppendorf,Martini
[5] University of Turin,Klinik Prostate Cancer Center
[6] European Institute of Oncology,Department of Urology, San Luigi Gonzaga Hospital
[7] Medical University of Vienna,Department of Urology
[8] I.M. Sechenov First Moscow State Medical University,Department of Urology, Comprehensive Cancer Center
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Combination therapy; Cytoreductive nephrectomy; Histology; Kidney cancer; SEER database; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 472
页数：11
相关论文
共 50 条
  • [21] Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
    Nayak, Brusabhanu
    Panaiyadiyan, Sridhar
    Singh, Prabhjot
    Karmakar, Subhradip
    Kaushal, Seema
    Seth, Amlesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 135.e9 - 135.e15
  • [22] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Nerich, Virginie
    Hugues, Marion
    Paillard, Marie Justine
    Borowski, Laetitia
    Nai, Thierry
    Stein, Ulrich
    Hon, Thierry Nguyen Tan
    Montcuquet, Philippe
    Maurina, Tristan
    Mouillet, Guillaume
    Kleinclauss, Francois
    Pivot, Xavier
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    ONCOTARGETS AND THERAPY, 2014, 7 : 365 - 374
  • [23] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Hugues, Marion
    Nerich, V
    Nai, T.
    Paillard, M. J.
    Borowski, L.
    Stein, U.
    Hon, Nguyen Tan T.
    Montcuquet, P.
    Maurina, T.
    Mouillet, G.
    Kleinclauss, F.
    Pivot, X.
    Thiery-Vuillemin, A.
    Limat, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 271 - 271
  • [24] Novel treatment strategies in clear-cell metastatic renal cell carcinoma
    van Spronsen, DJ
    de Weijer, KJM
    Mulders, PFA
    De Mulder, RHM
    ANTI-CANCER DRUGS, 2005, 16 (07) : 709 - 717
  • [25] Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy
    Perego, Gianluca
    Barzaghi, Paolo
    Vavassori, Ivano
    Petrelli, Fausto
    MEDICAL ONCOLOGY, 2020, 37 (09)
  • [26] Treating metastatic clear-cell renal cell carcinoma: beyond immunotherapy
    Gianluca Perego
    Paolo Barzaghi
    Ivano Vavassori
    Fausto Petrelli
    Medical Oncology, 2020, 37
  • [27] Papillary type 2 versus clear cell renal cell carcinoma: Survival outcomes
    Simone, G.
    Tuderti, G.
    Ferriero, M.
    Papalia, R.
    Misuraca, L.
    Minisola, F.
    Costantini, M.
    Mastroianni, R.
    Sentinelli, S.
    Guaglianone, S.
    Gallucci, M.
    EJSO, 2016, 42 (11): : 1744 - 1750
  • [28] Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy
    Garcia, Cristina Cano
    Flammia, Rocco S.
    Piccinelli, Mattia
    Panunzio, Andrea
    Tappero, Stefano
    Barletta, Francesco
    Incesu, Reha-Baris
    Law, Kyle W.
    Morra, Simone
    Tian, Zhe
    Saad, Fred
    Kapoor, Anil
    Shariat, Shahrokh F.
    Longo, Nicola
    Tilki, Derya
    Briganti, Alberto
    Terrone, Carlo
    Antonelli, Alessandro
    De Cobelli, Ottavio
    Hoeh, Benedikt
    Kluth, Luis A.
    Chun, Felix K. H.
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (01) : 1 - 6
  • [29] Improved survival in contemporary actively treated community-based metastatic clear-cell renal cell carcinoma patients
    Incesu, R. B.
    Morra, S. M.
    Scheipner, L.
    Baudo, A.
    Jannello, L. M., I
    de Angelis, M.
    Siech, C.
    Assad, A.
    Tian, Z.
    Saad, F.
    Shariat, S. F.
    Chun, F. K. H.
    Briganti, A.
    de Cobelli, O.
    Carmignani, L.
    Ahyai, S.
    Longo, N. L.
    Tilki, D.
    Graefen, M. G.
    Karakiewicz, P., I
    EUROPEAN UROLOGY, 2024, 85 : S1847 - S1847
  • [30] Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
    Y Chang
    H An
    L Xu
    Y Zhu
    Y Yang
    Z Lin
    J Xu
    British Journal of Cancer, 2015, 113 : 626 - 633
12345